# Cleveland Alzheimer's Disease Research Center

> **NIH NIH P30** · CLEVELAND CLINIC LERNER COM-CWRU · 2020 · $2,115,312

## Abstract

OVERALL
PROJECT SUMMARY
 The Cleveland Alzheimer’s Disease Research Center (CADRC) is a collaborative effort amongst
physicians and investigators from Case Western Reserve University (CWRU), the Cleveland Clinic Foundation
(CCF), Cleveland Ohio and Las Vegas, Nevada sites, the Metro Health System (MHS), University Hospitals
(UH), and the Louis Stokes Cleveland VA Medical Center (LSVA), to establish a National Institute on Aging
(NIA) funded Alzheimer’s disease research center. The CADRC would represent a rich clinical and research
community and an estimated 45,000 Nevadans and 220,000 Ohioans who suffer from Alzheimer’s disease
(AD). Currently there is no Alzheimer’s Disease Research Center in either Ohio or Nevada.
 The CADRC will bring together the considerable expertise from the medical and academic communities
in northeast Ohio and Nevada to focus on one of the largest health care crises facing our country. The CADRC
will be focused on the increasingly recognized clinical and pathologic heterogeneity observed in AD and AD-
Related Dementias (ADRD).
 The CADRC will create an infrastructure to help speed up the research efforts of local, national and
international investigators. The CADRC will participate in the national Alzheimer’s Centers program and
contribute to the “big science” possible when centers from around the country collaborate. We will recruit
subject samples that northeast Ohio and Nevada are well situated to study due to unique regional populations
or studies (dementia with Lewy bodies, repetitive head trauma, and rapidly progressive AD identified by the
National Prion Disease Pathology Surveillance Center,) or relevant to our understanding of AD and related
dementias (cognitively normal older individuals, AD and mild cognitive impairment). We will add value to the
evaluation of these subject samples by adding biofluid collection and analysis and cutting edge imaging.
Special emphasis will also be placed on enrollment of minority populations not often well-studied.
 We are quite encouraged by the collaborative spirit already demonstrated by those participating in the
CADRC planning from CWRU, CCF, MHS, UH, and LSVA and from the support we have received from the
northeast Ohio and Las Vegas communities. We believe this is a great opportunity for both Ohio and Nevada
to contribute to the greater efforts of the Alzheimer’s Disease Research Centers program and to improve the
treatments for these devastating disorders.

## Key facts

- **NIH application ID:** 9967961
- **Project number:** 5P30AG062428-02
- **Recipient organization:** CLEVELAND CLINIC LERNER COM-CWRU
- **Principal Investigator:** JAMES Bruce LEVERENZ
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $2,115,312
- **Award type:** 5
- **Project period:** 2019-07-01 → 2023-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9967961

## Citation

> US National Institutes of Health, RePORTER application 9967961, Cleveland Alzheimer's Disease Research Center (5P30AG062428-02). Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/grant/nih/9967961. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*